CXCR2 and cancer: Evidence suggests that tumor cells promote the release of NETs from neutrophils through stimulation, such as secretion of IL-8/CXCL8 and CXCR1/CXCR2 agonists, which provides an explanation for the link between NETs and cancer (56–58).